Obesity and endocrine disease

Endocrinology and Metabolism Clinics of North America

Volumn 32, Issue 4, 2003, Pages 895-914

  Kokkoris, Panagiotis ^a   Pi Sunyer, F Xavier ^b  

^a IASO GENERAL HOSPITAL   (Greece)

^b New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ADRENALIN; ALDOSTERONE; ANDROSTANOLONE; ANDROSTENEDIONE; CATECHOLAMINE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; ESTRADIOL; ESTRONE; FOLLITROPIN; GROWTH HORMONE; LIOTHYRONINE; LUTEINIZING HORMONE; NORADRENALIN; OSTEOCALCIN; PARATHYROID HORMONE; PROLACTIN; RENIN; SEX HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TESTOSTERONE; THYROGLOBULIN; THYROID HORMONE; THYROTROPIN; THYROXINE;

ADIPOCYTE; ALSTROM SYNDROME; BARDET BIEDL SYNDROME; BRAIN INJURY; BRAIN TUMOR; CUSHING DISEASE; DISEASE ASSOCIATION; ENDOCRINE DISEASE; ENZYME DEFICIENCY; GENE MUTATION; GROWTH HORMONE DEFICIENCY; HORMONAL REGULATION; HUMAN; HYPERPHAGIA; HYPOGONADISM; HYPOTHALAMUS; HYPOTHYROIDISM; INSULINOMA; OBESITY; OVARY POLYCYSTIC DISEASE; PRADER WILLI SYNDROME; PRIORITY JOURNAL; REVIEW; THYROID DISEASE;

EID: 0346102621     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(03)00078-1     Document Type: Review

References (124)

1. Chomard P, Vernhes G, Autissier N, et al. Serum concentrations of total T4, T3, reverse T3 and free T4, T3 in moderately obese patients. Hum Nutr Clin Nutr 1985;39(5):371-8.
2. de Rosa G, Della Casa S, Corsello SM, et al. Thyroid function in altered nutritional state. Exp Clin Endocrinol 1983;82(2):173-7.
3. Strata A, Ugolotti G, Contini C, et al. Thyroid and obesity: survey of some function tests in a large obese population. Int J Obes 1978;2(3):333-40.
4. Wilcox RG. Triiodothyronine, T.S.H., and prolactin in obese women. Lancet 1977;1(8020):1027-9.
5. Bray GA, Fisher DA, Chopra IJ. Relation of thyroid hormones to body-weight. Lancet 1976;1(7971):1206-8.
6. Donders SH, Pieters GF, Heevel JG, et al. Disparity of thyrotropin (TSH) and prolactin responses to TSH-releasing hormone in obesity. J Clin Endocrinol Metab 1985;61(1):56-9.
7. Buscemi S, Verga S, Maneri R, et al. Influences of obesity and weight loss on thyroid hormones. A 3-3.5-year follow-up study on obese subjects with surgical bilio-pancreatic by-pass. J Endocrinol Invest 1997;20(5):276-81.
8. Scriba PC, Bauer M, Emmert D, et al. Effects of obesity, total fasting and re-alimentation on L-thyroxine (T4), 3,5,3′-L-triiodothyronine (T3), 3,3′,5′-L-triiodothyronine (rT3), thyroxine binding globulin (TBG), cortisol, thyrotrophin, cortisol binding globulin (CBG), transferrin, alpha 2-haptoglobin and complement C'3 in serum. Acta Endocrinol (Copenh) 1979;91(4):629-43.
9. Astrup A, Buemann B, Christensen NJ, et al. The contribution of body composition, substrates, and hormones to the variability in energy expenditure and substrate utilization in premenopausal women. J Clin Endocrinol Metab 1992;74(2):279-86.
10. Svendsen OL, Hassager C, Christiansen C. Impact of regional and total body composition and hormones on resting energy expenditure in overweight postmenopausal women. Metabolism 1993;42(12):1588-91.
11. Toubro S, Sorensen TI, Ronn B, et al. Twenty-four-hour energy expenditure: the role of body composition, thyroid status, sympathetic activity, and family membership. J Clin Endocrinol Metab 1996;81(7):2670-4.
12. Davidson MB, Chopra IJ. Effect of carbohydrate and noncarbohydrate sources of calories on plasma 3,5,3′-triiodothyronine concentrations in man. J Clin Endocrinol Metab 1979;48(4):577-81.
13. Danforth E Jr, Horton ES, O'Connell M, et al. Dietary-induced alterations in thyroid hormone metabolism during overnutrition. J Clin Invest 1979;64(5):1336-47.
14. Vagenakis AG, Portnay GI, O'Brian JT, et al. Effect of starvation on the production and metabolism of thyroxine and triiodothyronine in euthyroid obese patients. J Clin Endocrinol Metab 1977;45(6):1305-9.
15. Eisenstein Z, Hagg S, Vagenakis AG, et al. Effect of starvation on the production and peripheral metabolism of 3,3′,5′-triiodothyronine in euthyroid obese subjects. J Clin Endocrinol Metab 1978;47(4):889-93.
16. Azizi F. Effect of dietary composition on fasting-induced changes in serum thyroid hormones and thyrotropin. Metabolism 1978;27(8):935-42.
17. Amatruda JM, Hochstein M, Hsu TH, et al. Hypothalamic and pituitary dysfunction in obese males. Int J Obes 1982;6(2):183-9.
18. Kopelman PG. Physiopathology of prolactin secretion in obesity. Int J Obes Relat Metab Disord 2000;24(Suppl 2):S104-8.
19. Carlson HE, Drenick EJ, Chopra IJ, et al. Alterations in basal and TRH-stimulated serum levels of thyrotropin, prolactin, and thyroid hormones in starved obese men. J Clin Endocrinol Metab 1977;45(4):707-13.
20. Copinschi G, De Laet MH, Brion JP, et al. Simultaneous study of cortisol, growth hormone and prolactin nyctohemeral variations in normal and obese subjects. Influence of prolonged fasting in obesity. Clin Endocrinol (Oxf) 1978;9(1):15-26.
21. Kopelman PG, White N, Pilkington TR, et al. Impaired hypothalamic control of prolactin secretion in massive obesity. Lancet 1979;1(8119):747-50.
22. Kopelman PG, Pilkington TR, Jeffcoate SL, et al. Persistence of defective hypothalamic control of prolactin secretion in some obese women after weight reduction. Br Med J 1980;281(6236):358-9.
23. Weaver JU, Noonan K, Kopelman PG. An association between hypothalamic-pituitary dysfunction and peripheral endocrine function in extreme obesity. Clin Endocrinol (Oxf) 1991;35(1):97-102.
24. Lala VR, Ray A, Jamias P, et al. Prolactin and thyroid status in prepubertal children with mild to moderate obesity. J Am Coll Nutr 1988;7(5):361-6.
25. Rojdmark S, Rossner S. Decreased dopaminergic control of prolactin secretion in male obesity: normalization by fasting. Metabolism 1991;40(2):191-5.
26. Plewe G, Schneider U, Krause U, et al. Naloxone increases the response of growth hormone and prolactin to stimuli in obese humans. J Endocrinol Invest 1987;10(2):137-41.
27. Weltman A, Weltman JY, Hartman ML, et al. Relationship between age, percentage body fat, fitness, and 24-hour growth hormone release in healthy young adults: effects of gender. J Clin Endocrinol Metab 1994;78(3):543-8.
28. Meistas MT, Foster GV, Margolis S, et al. Integrated concentrations of growth hormone, insulin, C-peptide and prolactin in human obesity. Metabolism 1982;31(12):1224-8.
29. Veldhuis JD, Iranmanesh A, Ho KK, et al. Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab 1991;72(1):51-9.
30. Cordido F, Casanueva FF, Dieguez C. Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity. J Clin Endocrinol Metab 1989;68(2):290-3.
31. Lee EJ, Kim KR, Lee KM, et al. Reduced growth hormone response to L-dopa and pyridostigmine in obesity. Int J Obes Relat Metab Disord 1994;18(7):465-8.
32. Copinschi G, Wegienka LC, Hane S, et al. Effect of arginine on serum levels of insulin and growth hormone in obese subjects. Metabolism 1967;16(6):485-91.
33. Bell JP, Donald RA, Espiner EA. Pituitary response to insulin-induced hypoglycemia in obese subjects before and after fasting. J Clin Endocrinol Metab 1970;31(5):546-51
34. Mims RB, Stein RB, Bethune JE. The effect of a single dose of L-dopa on pituitary hormones in acromegaly, obesity, and in normal subjects. J Clin Endocrinol Metab 1973;37(1):34-9.
35. Topper E, Gil-Ad I, Bauman B, et al. Plasma growth hormone response to oral clonidine as compared to insulin hypoglycemia in obese children and adolescents. Horm Metab Res 1984;16(Suppl 1):127-30.
36. Ross RJ. GH, IGF-1 and binding proteins in altered nutritional states. Int J Obes Relat Metab Disord 2000;24(Suppl 2):S92-5.
37. Rasmussen MH, Hvidberg A, Juul A, et al. Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects. J Clin Endocrinol Metab 1995;80(4):1407-15. Erratum appears in J Clin Endocrinol Metab 1995;80(8):2446.
38. Rasmussen MH, Hvidberg A, Juul A, et al. Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects. J Clin Endocrinol Metab 1995;80(4):1407-15. Erratum appears in J Clin Endocrinol Metab 1995;80(8):2446.
39. Kalkhoff R, Ferrou C. Metabolic differences between obese overweight and muscular overweight men. N Engl J Med 1971;284(22):1236-9.
40. Loche S, Cappa M, Borrelli P, et al. Reduced growth hormone response to growth hormone-releasing hormone in children with simple obesity: evidence for somatomedin-C mediated inhibition. Clin Endocrinol (Oxf) 1987;27(2):145-53.
41. Rudman D, Kutner MH, Rogers CM, et al. Impaired growth hormone secretion in the adult population: relation to age and adiposity. J Clin Invest 1981;67(5):1361-9.
42. Marin P, Kvist H, Lindstedt G, et al. Low concentrations of insulin-like growth factor-I in abdominal obesity. Int J Obes Relat Metab Disord 1993;17(2):83-9.
43. Frystyk J, Vestbo E, Skjaerbaek C, et al. Free insulin-like growth factors in human obesity. Metabolism 1995;44(10 Suppl 4):37-44.
44. Scacchi M, Pincelli AI, Cavagnini F. Growth hormone in obesity. Int J Obes Relat Metab Disord 1999;23(3):260-71.
45. Glass AR. Endocrine aspects of obesity. Med Clin North Am 1989;73(1):139-60.
46. Strain GW, Zumoff B, Kream J, et al. Sex difference in the influence of obesity on the 24 hr mean plasma concentration of cortisol. Metabolism 1982;31(3):209-12.
47. Copinschi G, Cornil A, Leclercq R, et al. Cortisol secretion rate and urinary corticoid excretion in normal and obese subjects. Acta Endocrinol (Copenh) 1966;51(2):186-92.
48. Kobberling J, zur Muhlen A von. The circadian rhythm of free cortisol determined by urine sampling at two-hour intervals in normal subjects and in patients with severe obesity or Cushing's syndrome. J Clin Endocrinol Metab 1974;38(2):313-9.
49. Pasquali R, Biscotti D, Spinucci G, et al. Pulsatile secretion of ACTH and cortisol in premenopausal women: effect of obesity and body fat distribution. Clin Endocrinol (Oxf) 1998;48(5):603-12.
50. Pasquali R, Cantobelli S, Casimirri F, et al. The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J Clin Endocrinol Metab 1993;77(2):341-6.
51. Marin P, Darin N, Amemiya T, et al. Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism 1992;41(8):882-6.
52. Katz JR, Taylor NF, Perry L, et al. Increased response of cortisol and ACTH to corticotrophin releasing hormone in centrally obese men, but not in post-menopausal women. Int J Obes Relat Metab Disord 2000;24(Suppl 2):S138-9.
53. Vamvakopoulos NC, Chrousos GP. Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimorphism of the stress response and immune/inflammatory reaction. J Clin Invest 1993;92(4):1896-902.
54. Pasquali R, Vicennati V, Gambineri A. Adrenal and gonadal function in obesity. J Endocrinol Invest 2002;25(10):893-8.
55. Ness-Abramof R, Nabriski D, Apovian CM, et al. Overnight dexamethasone suppression test: a reliable screen for Cushing's syndrome in the obese. Obes Res 2002;10(12):1217-21.
56. Yanovski JA, Yanovski SZ, Gold PW, et al. Differences in corticotropin-releasing hormone-stimulated adrenocorticotropin and cortisol before and after weight loss. J Clin Endocrinol Metab 1997;82(6):1874-8.
57. Tsagarakis S, Kokkoris P, Roboti C, et al. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome. Clin Endocrinol (Oxf) 1998;48(5):627-33.
58. Fok AC, Tan KT, Jacob E, et al. Overnight (1 mg) dexamethasone suppression testing reliably distinguishes non-cushingoid obesity from Cushing's syndrome. Steroids 1991;56(11):549-51.
59. Yanovski JA, Cutler GB Jr, Chrousos GP, et al. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states. JAMA 1993;269(17):2232-8.
60. Tsagarakis S, Vasiliou V, Kokkoris P, et al. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity. Clin Endocrinol (Oxf) 1999;51(4):473-7.
61. Barrett-Connor E, Khaw KT. Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study. Circulation 1988;78(3):539-45.
62. Amatruda JM, Harman SM, Pourmotabbed G, et al. Depressed plasma testosterone and fractional binding of testosterone in obese males. J Clin Endocrinol Metab 1978;47(2):268-71.
63. Glass AR, Swerdloff RS, Bray GA, et al. Low serum testosterone and sex-hormone-binding-globulin in massively obese men. J Clin Endocrinol Metab 1977;45(6):1211-9.
64. Strain GW, Zumoff B, Kream J, et al. Mild hypogonadotropic hypogonadism in obese men. Metabolism 1982;31(9):871-5.
65. Haffner SM, Valdez RA, Stern MP, et al. Obesity, body fat distribution and sex hormones in men. Int J Obes Relat Metab Disord 1993;17(11):643-9.
66. Pasquali R, Casimirri F, De Iasio R, et al. Insulin regulates testosterone and sex hormone-binding globulin concentrations in adult normal weight and obese men. J Clin Endocrinol Metab 1995;80(2):654-8.
67. Seidell JC, Bjorntorp P, Sjostrom L, et al. Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels. Metabolism 1990;39(9):897-901.
68. Strain GW, Zumoff B, Miller LK, et al. Effect of massive weight loss on hypothalamic-pituitary-gonadal function in obese men. J Clin Endocrinol Metab 1988;66(5):1019-23.
69. Pasquali R, Casimirri F, Cantobelli S, et al. Effect of obesity and body fat distribution on sex hormones and insulin in men. Metabolism 1991;40(1):101-4.
70. Kley HK, Edelmann P, Kruskemper HL. Relationship of plasma sex hormones to different parameters of obesity in male subjects. Metabolism 1980;29(11):1041-5.
71. Vermeulen A, Kaufman JM, Deslypere JP, et al. Attenuated luteinizing hormone (LH) pulse amplitude but normal LH pulse frequency, and its relation to plasma androgens in hypogonadism of obese men. J Clin Endocrinol Metab 1993;76(5):1140-6.
72. Leenen R, van der Kooy K, Seidell JC, et al. Visceral fat accumulation in relation to sex hormones in obese men and women undergoing weight loss therapy. J Clin Endocrinol Metab 1994;78(6):1515-20.
73. Schneider G, Kirschner MA, Berkowitz R, et al. Increased estrogen production in obese men. J Clin Endocrinol Metab 1979;48(4):633-8.
74. Landsberg L, Young JB. Fasting, feeding and regulation of the sympathetic nervous system. N Engl J Med 1978;298(23):1295-301.
75. Young JB, Landsberg L. Stimulation of the sympathetic nervous system during sucrose feeding. Nature 1977;269(5629):615-7.
76. Young JB, Landsberg L. Suppression of sympathetic nervous system during fasting. Science 1977;196(4297):1473-5.
77. Patel J, Coppack SW, Rawesh A, et al. Regional and total body changes in sympathoadrenal activity in response to eating. Int J Obes Relat Metab Disord 2000;24(Suppl 2):S156-7.
78. Young JB, Macdonald IA. Sympathoadrenal activity in human obesity: heterogeneity of findings since 1980. Int J Obes Relat Metab Disord 1992;16(12):959-67.
79. Landsberg L, Krieger DR. Obesity, metabolism, and the sympathetic nervous system. Am J Hypertens 1989;2(3) (Pt 2):125S-35S.
80. Troisi RJ, Weiss ST, Parker DR, et al. Relation of obesity and diet to sympathetic nervous system activity. Hypertension 1991;17(5):669-77.
81. Del Rio G, Carani C, Bonati M, et al. Sexual dimorphism of the autonomic nervous system response to weight loss in obese patients. Int J Obes Relat Metab Disord 1992;16(11):897-903.
82. Del Rio G. Adrenomedullary function and its regulation in obesity. Int J Obes Relat Metab Disord 2000;24(Suppl 2):S89-91.
83. Mannelli M, Lanzillotti R, Pupilli C, et al. Adrenal medulla secretion in Cushing's syndrome. J Clin Endocrinol Metab 1994;78(6):1331-5.
84. Hiramatsu K, Yamada T, Ichikawa K, et al. Changes in endocrine activities relative to obesity in patients with essential hypertension. J Am Geriatr Soc 1981;29(1):25-30.
85. Tuck ML, Sowers J, Dornfeld L, et al. The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N Engl J Med 1981;304(16):930-3.
86. Andersen T, McNair P, Fogh-Andersen N, et al. Increased parathyroid hormone as a consequence of changed complex binding of plasma calcium in morbid obesity. Metabolism 1986;35(2):147-51.
87. Bell NH, Epstein S, Greene A, et al. Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest 1985;76(1):370-3.
88. Patton ML, Brown MR, Lewis A, et al. Body weight and its effect on immunoreactive parathyroid hormone levels. Miner Electrolyte Metab 1983;9(3):151-3.
89. al-Adsani H, Hoffer LJ, Silva JE. Resting energy expenditure is sensitive to small dose changes in patients on chronic thyroid hormone replacement. J Clin Endocrinol Metab 1997;82(4):1118-25.
90. Orth DN. Cushing's syndrome. N Engl J Med 1995;332(12):791-803.
91. Bengtsson BA, Eden S, Lonn L, et al. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 1993;76(2):309-17.
92. Johannsson G, Marin P, Lonn L, et al. Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. J Clin Endocrinol Metab 1997;82(3):727-34.
93. Lovejoy JC, Bray GA, Greeson CS, et al. Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases abdominal fat in obese, older men. Int J Obes Relat Metab Disord 1995;19(9):614-24.
94. Vermeulen A, Goemaere S, Kaufman JM. Testosterone, body composition and aging. J Endocrinol Invest 1999;22(5 Suppl):110-6.
95. Lustig RH. The neuroendocrinology of obesity. Endocrinol Metab Clin North Am 2001;30(3):765-85.
96. Pinto G, Bussieres L, Recasens C, et al. Hormonal factors influencing weight and growth pattern in craniopharyngioma. Horm Res 2000;53(4):163-9.
97. Sorva R. Children with craniopharyngioma. Early growth failure and rapid postoperative weight gain. Acta Paediatr Scand 1988;77(4):587-92.
98. Stahnke N, Grubel G, Lagenstein I, et al. Long-term follow-up of children with craniopharyngioma. Eur J Pediatr 1984;142(3):179-85.
99. Montague CT, Farooqi IS, Whitehead JP, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997;387:903-8.
100. Farooqi IS, et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 1999;341:879-84.
101. Strobel A, Isaad T, Camoin L, et al. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet 1998;18:213-5.
102. Clement K, Vaisse C, Lahlou N, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998;392:398-401.
103. Jackson RS, Creemers JW, Ohagi S, et al. Obesity and impaired prohormone processing associated with mutation of the human prohormone convertase 1 gene. Nat Gen 1997;16:218-20.
104. Krude H, Biebermann H, Luck W, et al. Severe early-onset obesity, adrenal insufficiency, and red hair pigmentation caused by POMC mutations in humans. Nat Genet 1998;19:155-7.
105. Farooqi IS, Yeo GS, Keogh JM, et al. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest 2000;106:271-9.
106. Jeffcoate WJ, Laurance BM, Edwards CR, et al. Endocrine function in the Prader-Willi syndrome. Clin Endocrinol (Oxf) 1980;12(1):81-9.
107. Dekaban AS, Parks JS, Ross GT. Laurence-Moon syndrome: evaluation of endocrinological function and phenotypic concordance and report of cases. Med Ann Dist Columbia 1972;41(11):687-94.
108. Maffei P, Munno V, Marshall JD, et al. The Alstrom syndrome: is it a rare or unknown disease? Ann Ital Med Int 2002 Oct-Dec;17(4):221-8.
109. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse gene and its human homologue. Nature 1994;372:425-32.
110. Hotamisligil GS, Spiegelman BM. Tumor necrosis factor-a: a key component of the obesity-diabetes link. Diabetes 1994;43:1271-8.
111. Alessi MC, Peiretti F, Morange P, et al. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible line between visceral fat accumulation and vascular disease. Diabetes 1997;46:860-7.
112. Yudkin JS, Kumari M, Humphries SE, et al. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000;148:209-14.
113. Weyer C, Tataranni PA, Pratley RE. Insulin action and insulinemia are closely related to the fasting complement C3, but not acylation-stimulating protein concentration. Diabetes Care 2000;23:779-85.
114. Maeda K, Okubo K, Shimomura I, et al. CDNA cloning and expression of a novel adipose-specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). Biochem Biophys Res Commun 1996;221:286-9.
115. Scherer PE, Williams S, Fogliano M, et al. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995;270:26746-9.
116. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996;18:10697-703.
117. Kondo H, Shimomura I, Matsukawa Y, Kumada M, Takahashi M, Matsuda M, et al. Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome. Diabetes 2002;51:2325-8.
118. Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Weyer C, Lindsay RS, et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 2002;51:1884-8.
119. Reference deleted in Proof.
120. Statnick MA, Beavers LS, Conner LJ, et al. Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes. Int J Reprod Diabetes Res 2000;1:51-8.
121. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83.
122. Rask E, Olsson T, Soderberg S, et al. Tissue-specific dysregulation of cortisol metabolism in human obesity. JCEM 2001;86:1418-21.
123. Andrew R, Phillips DIW, Walker BR. Obesity and gender influence cortisol secretion and metabolism in man. JCEM 1998;83:1806-9.
124. Stewart PM, Boulton A, Kumar S, et al. Cortisol metabolism in human obesity: impaired cortisone to cortisol conversion in subjects with central obesity. JCEM 1999;84:1022-7.